chr3-43079574-G-A

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_032806.6(POMGNT2):​c.*115C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000175 in 743,900 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.000017 ( 0 hom. )

Consequence

POMGNT2
NM_032806.6 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.751

Publications

0 publications found
Variant links:
Genes affected
POMGNT2 (HGNC:25902): (protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)) This gene encodes a protein with glycosyltransferase activity although its function is not currently known. [provided by RefSeq, Sep 2012]
POMGNT2 Gene-Disease associations (from GenCC):
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • myopathy caused by variation in POMGNT2
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032806.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMGNT2
NM_032806.6
MANE Select
c.*115C>T
3_prime_UTR
Exon 2 of 2NP_116195.2
POMGNT2
NM_001437285.1
c.*115C>T
3_prime_UTR
Exon 3 of 3NP_001424214.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMGNT2
ENST00000344697.3
TSL:1 MANE Select
c.*115C>T
3_prime_UTR
Exon 2 of 2ENSP00000344125.2Q8NAT1
POMGNT2
ENST00000441964.1
TSL:4
c.*115C>T
3_prime_UTR
Exon 3 of 3ENSP00000408992.1Q8NAT1
POMGNT2
ENST00000686643.1
c.*115C>T
3_prime_UTR
Exon 4 of 4ENSP00000509123.1Q8NAT1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.0000175
AC:
13
AN:
743900
Hom.:
0
Cov.:
10
AF XY:
0.0000290
AC XY:
11
AN XY:
379058
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
17874
American (AMR)
AF:
0.00
AC:
0
AN:
21334
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15474
East Asian (EAS)
AF:
0.00
AC:
0
AN:
33220
South Asian (SAS)
AF:
0.000245
AC:
13
AN:
53030
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39774
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2640
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
524904
Other (OTH)
AF:
0.00
AC:
0
AN:
35650
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
2
Bravo
AF:
0.00000378

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.9
DANN
Benign
0.41
PhyloP100
-0.75

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75583919; hg19: chr3-43121066; API